SCHEMBL7412460

SCHEMBL7412460

COC(=O)CC(C)C(=O)c1ccc2c(c1)CNC(=O)N2C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
CASP3 P42574 1/20 0.34
POLB P06746 1/20 0.34
ALDH1A1 P00352 4/20 0.33
SMYD3 Q9H7B4 1/20 0.33
KDM4E B2RXH2 3/20 0.32
GAA P10253 2/20 0.32
HSD17B10 Q99714 2/20 0.32
GLA P06280 1/20 0.32
RAB9A P51151 2/20 0.32
KAT2B Q92831 1/20 0.32
SRD5A1 P18405 2/20 0.31
SRD5A2 P31213 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
HTT P42858 1/20 0.30
TP53 P04637 1/20 0.30
ALOX15 P16050 1/20 0.30
CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412499 0.80 MAPT (0.37) MAPTHPGDSMN1; SMN2CASP3POLB
SCHEMBL7414611 0.79 PDE3B (0.49) SMYD3
SCHEMBL23535779 0.79 CASP3 (0.54) MAPTHPGDSMN1; SMN2CASP3POLB
SCHEMBL30040559 0.79 CASP3 (0.54) MAPTHPGDSMN1; SMN2CASP3POLB
SCHEMBL9729853 0.77 SMN1; SMN2 (0.53) MAPTSMN1; SMN2POLBALDH1A1HTT
SCHEMBL7343775 0.75 CYP11B2 (0.40) POLBALDH1A1HSD17B10
SCHEMBL23535782 0.74 LMNA (0.49) MAPTHPGDPOLBALDH1A1SMYD3
SCHEMBL30040376 0.74 LMNA (0.49) MAPTHPGDPOLBALDH1A1SMYD3
SCHEMBL7342699 0.73 USP30 (0.46) MAPTSMN1; SMN2POLBALDH1A1KDM4E
SCHEMBL9589587 0.72 SLC9A1 (0.43) MAPTHPGDSMN1; SMN2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4906630-A Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds RORER PHARMACEUTICAL CORPORATION (US) 1990-03-06 US disclosed
US-4868300-A INOTROPIC AGENTS, CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1989-09-19 US disclosed
US-4785101-A CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1988-11-15 US disclosed
EP-0247177-A4 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES. RORER INTERNAT OVERSEAS INC (US) 1988-04-06 EP disclosed
US-4725686-A CONGESTIVE HEART FAILURE WILLIAM H. RORER, INC. (US) 1988-02-16 US disclosed
EP-0247177-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1987-12-02 EP disclosed
WO-1987003201-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1987-06-04 WO disclosed